- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 5/0775 - Mesenchymal stem cells; Adipose-tissue derived stem cells
Patent holdings for IPC class C12N 5/0775
Total number of patents in this class: 4078
10-year publication summary
249
|
293
|
328
|
318
|
380
|
341
|
407
|
396
|
416
|
98
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Mesoblast International Sàrl | 132 |
58 |
The Regents of the University of California | 18943 |
46 |
Osaka University | 3143 |
38 |
Samsung Life Public Welfare Foundation | 588 |
35 |
Agency for Science, Technology and Research | 3512 |
34 |
Children's Medical Center Corporation | 1780 |
32 |
Mesoblast, Inc. | 68 |
28 |
FUJIFILM Corporation | 27102 |
26 |
Otsuka Pharmaceutical Factory, Inc. | 301 |
26 |
Kaneka Corporation | 4445 |
25 |
SanBio, Inc. | 61 |
25 |
Rohto Pharmaceutical Co., Ltd. | 349 |
23 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
21 |
Rutgers, The State University of New Jersey | 1776 |
21 |
Sapporo Medical University | 141 |
21 |
Tohoku University | 2526 |
21 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
20 |
The Trustees of Columbia University in the City of New York | 3440 |
19 |
SCM LifeScience Co., Ltd. | 29 |
19 |
Takeda Pharmaceutical Company Limited | 2961 |
18 |
Other owners | 3522 |